-+ 0.00%
-+ 0.00%
-+ 0.00%

INHIBRX BIOSCIENCES - EXPECTS INITIAL PHASE 1/2 ORDASTOBART RESULTS IN NSCLC IN MID-2027

Reuters·11/13/2026 21:06:33